Options: Hide MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic renal insufficiency | x | x | x | x | x | x | ||||||||
| Diabetic ketoacidosis | x | x | x | |||||||||||
| Hypoglycaemia | x | |||||||||||||
| Hypoglycemic reaction | x | x | x | x | x | x | ||||||||
| Pancreatitis | x | x | x | |||||||||||
| Renal impairment | x | x | x | x | x | x | ||||||||
| Type 1 diabetes mellitus | x | x | x | |||||||||||
| Type 2 diabetes mellitus | x | x | x | x | x | x | x | x | ||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |